The Kable

Home
Notes
Friday Kable
Longish Reads
Archive
About
💊 LMICs free from J&J’s TB drug patents; Malaria vaccine likely to get WHO approval; ModeX wins BARDA contract
#440 | Prison for anti-vaxxers in Pakistan; Malaria’s Malaysian comeback; Au revoir to French poultry in the US
 • 
Ria
 and 
Vinod
💉 AfDB's country reports to guide climate talks; Yamaha revs into healthcare; Routine immunisation rebounds
#439 | Potential new NASH treatment; Fighting TB better; A new avenue for Alzheimer's research
 • 
Ria
 and 
Vinod
💊 Ginkgo, Pfizer's new RNA collab; The cost of clean air; Throwing DARTS at resistant bacteria
#438 | India becomes older; Birds become well travelled; Scientists become inspired by octopi
 • 
Ria
 and 
Vinod
Most Popular
View all
💊 Gilead takes a shot at multiple myeloma; The WHO takes AMR advice to an app; Drug trials on lab cells in India soon
 • Vinod
💊 Pfizer's philanthropic pursuits; Gates Foundation goes further; TB to be or not to be?
 • Ria and Vinod
💊 LifeArc invests in African scientists; WuXi Biologics partners with Boostimmune; Pfizer gets accelerated approval for myeloma antibody
 • Ria and Vinod
💊 CEPI invests in Nipah research; Daewoong makes its way to Africa; Vaxxas’ new Australian Biomedical Facility
 • Ria and Vinod
💊 The UK’s Life Sci for Growth package; The WHO’s new NCD best buys; Korea’s new global biomanufacturing training hub
 • Ria and Vinod

Friday Kable

See all
💉 AfDB's country reports to guide climate talks; Yamaha revs into healthcare; Routine immunisation rebounds
#439 | Potential new NASH treatment; Fighting TB better; A new avenue for Alzheimer's research
 • 
Ria
 and 
Vinod
💉EuBiologics transfers tech to Biovac; Evaxion collaborates with Afrigen Biologics; Egypt cooperates with Africa on health
#434 | Suppression > expression; Known devil > aspartame; Making promises > keeping them
 • 
Ria
 and 
Vinod
💉 The Asia-Africa cholera corridor; Mpox joins China's Category B; J&J sheds its old skin
#429 | Giving brain cancer a death wish; Fighting acne with animal meds; Fighting emissions with $$$$
 • 
Ria
 and 
Vinod

Recent posts

See all
💉EuBiologics transfers tech to Biovac; Evaxion collaborates with Afrigen Biologics; Egypt cooperates with Africa on health
#434 | Suppression > expression; Known devil > aspartame; Making promises > keeping them
 • 
Ria
 and 
Vinod
💊 A historic, non-binding pandemic declaration; India tries to build back pharma trust; Repeat offender Novartis under PMCPA fire
#433 | When are we happiest?; Eating what makes us saddest?; What makes T cells exhausted?
 • 
Ria
 and 
Vinod
1
💊 Novo dials up Aspen for insulin for Africa; Novartis dials down another deal with BeiGene; Bio Farma partners CEPI
#432 | New marker for autoimmune conditions; Danaher cuts TB test prices; Dopamine-based decision-making pits speed against accuracy
 • 
Ria
 and 
Vinod
💊 BioNTech to advance mpox vaccine; Sanofi to offload CNS drugs; GSK gets an FDA nod
#431 | Oxford launches a trial for MERS vaccine; A grant to bring AI ultrasound tech to LMICs; A(nother) reason to work remotely
 • 
Ria
 and 
Vinod
💊 Germany finances vaccine development in South Africa; Uganda hopes to locally develop FMD vaccine; US NIH begins testing universal flu…
#430 | Inverse vaccines against autoimmunity; Anti-ageing drugs for transplant donors; Hedonism ftw
 • 
Ria
 and 
Vinod
💉 The Asia-Africa cholera corridor; Mpox joins China's Category B; J&J sheds its old skin
#429 | Giving brain cancer a death wish; Fighting acne with animal meds; Fighting emissions with $$$$
 • 
Ria
 and 
Vinod
The Kable
The Kable
The day's news and events at the intersection of human and animal health, climate change and environmental science. Get a unique perspective on healthcare opportunities and potential gaps.

The Kable

AboutArchiveSitemap
© 2023 The Kable
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing